Swedish Orphan Biovitrum (Belgium) (SRL)

Active
VAT

BE 0536.217.087

Address
Luchthaven Brussel Nationaal 1K
1930 Zaventem
Established
27-06-2013
Principal activity
Business and other management consultancy activities

Crisis resilience of Swedish Orphan Biovitrum (Belgium)

Which companies are best armed against current economic trends and the energy crisis?

Read more

Financial data of Swedish Orphan Biovitrum (Belgium)

2023 Financial statements 2022 Financial statements 2021 Financial statements 2020 Financial statements
Turnover €7,713,461
26%
€6,106,443
-21%
€7,708,961
-18%
€9,380,356
Profit/Loss €1,165,567
113%
€547,192
-49%
€1,083,501
-10%
€1,201,933
Equity €6,905,224
20%
€5,739,658
11%
€5,192,465
26%
€4,108,964
Gross margin €5,576,161
20%
€4,644,086
-19%
€5,759,296
-15%
€6,791,269
Employees 15,8 FTE
-4%
16,4 FTE
14%
14,4 FTE
19%
12,1 FTE

Frequently asked questions

What is the VAT number of Swedish Orphan Biovitrum (Belgium)?
The VAT number of Swedish Orphan Biovitrum (Belgium) is BE0536217087.
When was Swedish Orphan Biovitrum (Belgium) founded?
Swedish Orphan Biovitrum (Belgium) was founded on 27-06-2013.
What is the address of Swedish Orphan Biovitrum (Belgium)?
The current registered office of Swedish Orphan Biovitrum (Belgium) is located at Luchthaven Brussel Nationaal 1K, 1930 Zaventem.
When was the last time Swedish Orphan Biovitrum (Belgium) filed their annual financial statements?
The most recent financial statements of Swedish Orphan Biovitrum (Belgium) were filed on 08-05-2024. You can view them here.
How many employees does Swedish Orphan Biovitrum (Belgium) have?
There are 15,8 FTEs working at Swedish Orphan Biovitrum (Belgium) according to the staff figures in the most recent financial statements.
What is the annual turnover of Swedish Orphan Biovitrum (Belgium)?
At the time of its most recent financial statements, Swedish Orphan Biovitrum (Belgium) recorded a total turnover of €7,713,461.50.
Address

  You have disabled Javascript on your computer. To use this website, please enable Javascript first.


More details